title: Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment.
abstract: Injectable treatments, such as glucagon-like peptide-1 receptor agonists and insulin, are options for the pharmacologic treatment of type 2 diabetes. Numerous barriers lead to delay in initiating injectable treatment, which, in turn, may lead to inadequate glycemic control and increased risk of diabetes-related complications, underscoring the need to understand and address these barriers. Barriers to the initiation of injectable therapy, strategies to mitigate barriers, and information about needle attributes and their relation to needle pain are reviewed on the basis of published literature retrieval and our clinical experience. Barriers to the initiation of injectable therapy originate from both patients and practitioners. Anxiety about and fear of injection-associated pain has been estimated to affect approximately 30%-50% of patients before the initiation of diabetes education interventions. Advances in needle design have minimized the pain associated with injections, and recent data suggest that actual pain and bleeding associated with various needle gauges (21-gauge to 31-gauge) are mild. Other barriers include concerns about the ability to handle injectable therapy, concerns about treatment side effects, and impacts on quality of life. Practitioners can help to mitigate barriers to injectable treatment for type 2 diabetes by understanding patient perceptions, improving education, and setting realistic expectations about therapy. Strategies for minimizing injection-associated fear and anxiety include a combination of assessment, appropriate needle selection, patient education, behavioral interventions, and monitoring.
authors: Henry Ford Health System, Detroit, MI, USA.
authors: Davida F
authors: DF
authors: Kruger
authors: Amylin Pharmaceuticals, San Diego, CA, USA ; AstraZeneca, San Diego, CA, USA.
authors: Susan
authors: S
authors: LaRue
authors: AstraZeneca, San Diego, CA, USA.
authors: Phil
authors: P
authors: Estepa
keywords: anxiety; fear; injection; needle; type 2 diabetes
references: Diabetes Technol Ther. 2009 Feb;11(2):81-6
references: 19848573
references: Diabetes Care. 2013 Jan;36 Suppl 1:S11-66
references: 23264422
references: Diabetes Technol Ther. 2013 Jul;15(7):550-5
references: 23621793
references: Diabetes Care. 2012 Jun;35(6):1364-79
references: 22517736
references: Somatosens Mot Res. 2006 Mar-Jun;23(1-2):37-43
references: 16846958
references: Diabetes. 2009 Apr;58(4):773-95
references: 19336687
references: Rev Bras Ginecol Obstet. 2013 Mar;35(3):111-6
references: 23538469
references: Diabet Med. 2001 Aug;18(8):671-4
references: 11553207
references: BMJ. 1991 Jul 6;303(6793):26-7
references: 1859951
references: Diabet Med. 2005 Oct;22(10):1379-85
references: 16176200
references: J Pediatr Nurs. 2011 Dec;26(6):589-92
references: 21925589
references: Curr Med Res Opin. 2010 Jan;26(1):231-8
references: 19921965
references: Curr Med Res Opin. 2009 Jun;25(6):1413-20
references: 19422281
references: Diabet Med. 2013 Jul;30(7):789-98
references: 23710839
references: Am J Manag Care. 2012 Mar;18(3):139-46
references: 22435907
references: Diabet Med. 2009 Jan;26(1):28-33
references: 19125757
references: Rev Diabet Stud. 2005 Spring;2(1):35-9
references: 17491657
references: Diabetes Technol Ther. 2009 Aug;11(8):523-8
references: 19698066
references: Diabetes Care. 2001 Jun;24(6):1069-78
references: 11375373
references: Diabetes Educ. 2012 Jan-Feb;38(1):94-100
references: 22222513
references: Diabetes Educ. 2004 Mar-Apr;30(2):274-80
references: 15095517
references: J Pediatr Psychol. 2008 Sep;33(8):842-54
references: 18387963
references: Diabetes Care. 2010 Sep;33(9):1940-4
references: 20585002
references: Diabetes Technol Ther. 2011 Jul;13(7):737-41
references: 21476936
references: Diabetes Care. 2005 Sep;28(9):2243-5
references: 16123499
references: Diabetes Care. 2008 Dec;31(12):2398-403
references: 19033420
references: MCN Am J Matern Child Nurs. 2001 Mar-Apr;26(2):72-8
references: 11265439
references: Clin Ther. 2004 Oct;26(10):1663-78
references: 15598483
references: Patient Prefer Adherence. 2013 May 20;7:419-34
references: 23737662
references: BMJ. 2000 Aug 12;321(7258):405-12
references: 10938048
references: J Diabetes Sci Technol. 2012 Mar 01;6(2):328-35
references: 22538142
references: Diabetes Care. 2005 Oct;28(10):2543-5
references: 16186296
references: Diabet Med. 2007 Apr;24(4):350-8
references: 17335466
references: Diabet Med. 2006 Nov;23(11):1165-73
references: 17054590
references: Diabetes Care. 2000 Jul;23(7):934-42
references: 10895843
references: Diabetes Care. 2005 Nov;28(11):2673-9
references: 16249538
references: Patient Prefer Adherence. 2013 Sep 18;7:937-49
references: 24086104
references: J Diabetes Sci Technol. 2012 Mar 01;6(2):389-93
references: 22538152
references: Diabetes Ther. 2013 Dec;4(2):175-94
references: 23990497
references: J Diabetes Sci Technol. 2007 Sep;1(5):725-9
references: 19885141
references: Endocr Pract. 2013 May-Jun;19(3):536-57
references: 23816937
references: Singapore Med J. 2011 Nov;52(11):801-9
references: 22173249
references: Diabetes Res Clin Pract. 2011 Jan;91(1):54-60
references: 21074887
references: J Diabetes Complications. 2007 Jul-Aug;21(4):220-6
references: 17616351
references: Diabetes Care. 2010 Apr;33(4):733-5
references: 20086256
references: Diabetes Educ. 2009 Nov-Dec;35(6):1014-22
references: 19934459
references: Diabetes Care. 2004 Jan;27 Suppl 1:S106-9
references: 14693942